🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

313,52 USD

Máx. histórico

322,75

4 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-2,86%

Rango 52 semanas

175,89 – 326,63

Variación hoy

+2,12%

Cierre anterior

307,02

Rango de hoy

309,46 – 317,76

Volumen hoy

195.564

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
33,04 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
350,92 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 16 horas
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
31/03/1995 25,27 25,27 22,46 25,27 +12,50% 11,11% 1.336
30/03/1995 23,39 23,86 22,46 22,46 -7,69% 6,00% 3.446
29/03/1995 23,39 26,20 23,39 24,33 -1,89% 12,00% 1.469
28/03/1995 24,33 24,80 24,33 24,80 +0,00% 1,92% 4.275
27/03/1995 24,80 24,80 24,80 24,80 -5,36% 0,00% 1.336
24/03/1995 27,14 27,14 25,27 26,20 +0,00% 6,90% 3.099
23/03/1995 25,27 26,20 25,27 26,20 +3,70% 3,70% 214
22/03/1995 25,27 26,20 25,27 25,27 -3,57% 3,70% 4.836
21/03/1995 25,73 26,20 25,73 26,20 +0,00% 1,82% 3.687
20/03/1995 25,27 27,14 25,27 26,20 +0,00% 7,41% 5.931
17/03/1995 27,14 27,14 25,27 26,20 +0,00% 6,90% 454
16/03/1995 25,27 26,20 25,27 26,20 +0,00% 3,70% 7.561
15/03/1995 25,73 27,14 25,27 26,20 +0,00% 7,27% 5.611
14/03/1995 25,73 26,20 25,27 26,20 +1,82% 3,64% 10.900
13/03/1995 25,27 27,14 25,27 25,73 -1,79% 7,41% 989
10/03/1995 25,27 26,67 25,27 26,20 +3,70% 5,56% 2.030
09/03/1995 26,20 27,14 25,27 25,27 -3,57% 7,14% 10.927
08/03/1995 27,14 27,14 25,27 26,20 +0,00% 6,90% 11.301
07/03/1995 26,20 29,01 25,73 26,20 +0,00% 12,50% 8.175
06/03/1995 27,14 27,14 25,27 26,20 +3,70% 6,90% 5.931
03/03/1995 25,27 27,14 25,27 25,27 +3,85% 7,41% 5.210
02/03/1995 26,20 26,20 24,33 24,33 -1,89% 7,14% 4.675
01/03/1995 24,33 24,80 24,33 24,80 -3,64% 1,92% 2.618
28/02/1995 24,33 26,20 24,33 25,73 +0,00% 7,69% 1.469
27/02/1995 26,20 26,20 25,27 25,73 +0,00% 3,57% 10.927
24/02/1995 26,20 26,20 24,33 25,73 +3,77% 7,14% 7.427
23/02/1995 26,20 26,20 24,33 24,80 -1,85% 7,14% 588
22/02/1995 24,80 26,20 24,33 25,27 -3,57% 7,55% 12.477
21/02/1995 24,80 26,20 24,33 26,20 +7,69% 7,55% 5.931
17/02/1995 24,33 25,27 24,33 24,33 -7,14% 3,85% 33.182